Dr. Gotlib is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
875 Blake Wilbur Dr
Rm 2324
Stanford, CA 94305Phone+1 650-736-1253Fax+1 650-736-1253
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 1997 - 1999
- Stanford University School of MedicineClass of 1995
Certifications & Licensure
- CA State Medical License 1996 - 2026
- HI State Medical License 1997 - 1997
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Prognostic impact of expression of CD2, CD25, and/or CD30 in/on mast cells in systemic mastocytosis: a registry study of the European Competence Network on Mastocytosis.Axel Rüfer, Henning Nilius, Olivier Hermine, Marek Niedoszytko, Joanne N G Oude Elberink
Leukemia. 2025-01-15 - 1 citationsHarmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM.Peter Valent, Karin Hartmann, Gregor Hoermann, Andreas Reiter, Iván Alvarez-Twose
The Journal of Allergy and Clinical Immunology. in Practice. 2024-12-01 - 6 citationsProposals for revised International Working Group-European LeukemiaNet criteria for anemia response in myelofibrosis.Ayalew Tefferi, Giovanni Barosi, Francesco Passamonti, Juan-Carlos Hernandez-Boluda, Prithviraj Bose
Blood. 2024-10-24
Press Mentions
- Higher Stakes in Systemic MastocytosisJune 18th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: